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Relation of Coronary Blood Flow and Reactive Hyperemia to Regional
Dysfunction Induced by Dopamine Infusion in Dogs: Limitations in
Detecting Subcritical Coronary Stenoses
JOHN McB. HODGSON, MD, G. B. JOHN MANCINI, MD, FRCP(C), FACC
Ann Arbor, Michigan
Sympathomimetic agents have been used clinically to
elicit regional dysfunction or heterogeneity of coronary
blood flow to detect coronary artery lesions. However,
the usefulness of this procedure in detecting mild to mod-
erate coronary stenoses has not been defined previously.
This was investigated in 10 open chest anesthetized dogs
using subendocardial ultrasonic crystals to measure seg-
ment lengths. An electromagnetic flowprobe was placed
on the proximal left anterior descending artery, and
graded coronary stenoses were created using a cuff oc-
cluder. In the first phase of the study, subcritical coro-
nary stenoses were created which impaired maximal
postocclusion reactive hyperemia, but not coronary blood
flow at rest. A constant infusion of dopamine (average
15 Itg/kg per min) was then administered. Regional dys-
function during dopamine infusion was not consistently
observed despite production of coronary stenoses re-
sulting in total loss of reactive hyperemia at rest. Re-
gional function during dopamine treatment was, how-
Beta-adrenergic agonists are known to improve myocardial
contractility, but in the setting of coronary artery stenoses
they may also enhance regional heterogeneity of myocardial
blood flow or result in regional myocardial dysfunction
(1-4). For this reason, they have been employed clinically
in attempts to detect coronary artery lesions, particularly in
patients physically unable to increase myocardial oxygen
demands by exercise.
The utility of beta-adrenergic stimulation to detect mild
to moderate coronary stenoses has not been previously in-
vestigated in an animal model. Therefore, we investigated
the relation between graded subcritical coronary stenoses
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ever, critically related to the actual changes in coronary
blood flow during the infusion.
In the second phase of the study, regional function
during dopamine challenge was investigated during pro-
gressive impairments of coronary blood flow. Regional
function was maintained until coronary blood flow dur-
ing the infusion was reduced to near rest levels below
which regional function deteriorated rapidly.
It is concluded that: 1) dopamine infusion is insen-
sitive for the detection of mild to moderate coronary
stenoses defined on the basis of subcritical impairments
of coronary blood flowreserve; 2) regional function dur-
ing dopamine infusion is maintained provided that coro-
nary blood flow is maintained at or above rest levels;
and 3) measurement of coronary flow reserve at rest is
more sensitivefor the detection of coronary stenoses than
is induction of regional dysfunction during dopamine
infusion.
(J Am Coli CardioI1985;5:664-71)
defined on the basis of coronary blood flow reserve at rest
and regional myocardial function during dopamine hydro-
chloride infusion in an acute, anesthetized dog model. In
addition, the relation of blood flow to myocardial function
during dopamine infusion was evaluated.
Methods
Animal preparation. Ten mongrel dogs of either sex
(average weight 22.8 kg, range 19.1 to 30.4) were anes-
thetized with intravenous pentobarbital sodium (35 mg/kg)
and ventilated with room air using a Harvard respirator. A
left thoracotomy was performed in the fifth intercostal space.
The left anterior descending coronary artery was dissected
free for a length of 2 to 3 em and instrumented with two
cuff occluders and an appropriately sized electromagnetic
flow probe (Carolina Medical Electronics, Inc.). All flow
probes were calibrated using timed collections of blood of
known hematocrit infused at physiologic blood flow rates.
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Two pairs of subendocardial ultrasonic quartz crystals were
implanted parallel to the myocardial fibers (5); one pair in
the left anterior descending coronary artery distribution dis-
tal to the occluder and in the central area of the zone to be
rendered ischemic (ischemic zone) and one pair in the left
circumflex coronary artery region (nonischemic zone). These
were connected to a Sonomicrometer 120 (Triton Technol-
ogy). Proper crystal alignment was confirmed by oscillo-
scopic display of the sonomicrometer signals (Tektronics,
Inc., model 2213A) during the experiment. Proper position
in the subendocardium was also confirmed at the end of
each experiment by direct inspection of the crystal position
after the dog was killed. All crystals were within the inner
one-third of the myocardial wall. An 8F high fidelity mi-
cromanometer (Millar Instruments) was passed retrograde
through the carotid artery into the left ventricle for mea-
surement of left ventricular pressure and its first derivative
(dP/dt). The lumen of this catheter was used to record left
ventricular end-diastolic pressure using a fluid-filled Sta-
tham P-50 transducer.
Experimental protocol. Heart rate, rate of left ventric-
ular pressure change with time (dP/dt), left ventricular pres-
sure, subendocardial segment lengths for the left anterior
descending coronary artery and left circumflex regions and
phasic and mean coronary blood flow were recorded con-
tinuously. In 8 of the 10 dogs, coronary stenoses were
characterized by the degree to which they impaired reactive
hyperemia. Reactive hyperemia was assessed using a 20
second period of complete coronary occlusion produced by
the distal occiuder. Blood flow and segment lengths were
allowed to return to baseline level between successive re-
active hyperemia determinations. After control reactive hy-
peremia was determined in triplicate, function was recorded
at rest and after a 5 minute intravenous infusion of dopamine
(average 15.6 p,g/kg per min). The dopamine infusion was
then discontinued, and all variables were allowed to return
to baseline level.
A subcritical coronary stenosis was created using the
proximal occluder. Reactive hyperemia was again deter-
mined with the stenosis in place. The stenosis was consid-
ered stable if the reactive hyperemia ratio (hyperemic flow/rest
flow) was within 10% on three successive determinations.
Function was again recorded at rest and after a 5 minute
infusion of dopamine. Four to five different stenoses per
dog were created and characterized in this way. The severity
of the lesions and the order in which they were produced
were varied randomly. For the purposes of this portion of
the investigation, the most severe coronary stenosis created
in each dog was defined by abolition of postocclusion re-
active hyperemia without reduction of coronary blood flow
at rest. Lesions that reduced coronary blood flow at rest
were avoided.
In seven of these dogs. the relation of coronary blood
flow to regional function during dopamine infusion was
further investigated. Regional function was first recorded
at rest. A constant intravenous infusion of dopamine was
then administered. The infusion rate was determined as the
dose that resulted in a two- to three-fold increase in coronary
blood flow from basal levels. After stabilization at this dose,
regional function was again recorded in the absence of a
coronary stenosis. Subsequently, during the continued do-
pamine infusion, graded coronary stenoses were created
using the proximal occluder and were adjusted to produce
stepwise impairment of coronary blood flow. Function was
again recorded at each level of reduced coronary blood flow
after all variables had been stable for 1 minute (total of two
to four minutes of infusion at each stage). Finally, regional
function was recorded 1 minute after total coronary occlusion.
Data analysis. Each tracing was analyzed for mean left
anterior descending coronary artery blood flow, heart rate,
left ventricular systolic and end-diastolic pressures, peak
positive and negative dP/dt (rate of change of pressure with
time), and end-diastolic and end-systolic segment lengths
for the left anterior descending coronary artery and left
circumflex regions. End-diastolic segment lengths and left
ventriclar end-diastolic pressures were determined at the
beginning of left ventricular contraction when the dP/dt
became positive. End-systolic segment lengths were deter-
mined 20 ms before or at peak negative dP/dt (2). Percent
systolic shortening was determined by calculating the ratio
of end-diastolic segment length minus end-systolic segment
length to end-diastolic segment length multiplied by 100.
All measurements were obtained by averaging data from
three normally conducted beats. These were made twice (at
rest and during dopamine infusion) in the absence of stenosis
and for each new level of coronary stenosis.
The reactive hyperemia ratio for each lesion was defined
by dividing the maximal coronary blood flow after a 20
second coronary occlusion by coronary blood flow at rest.
This was expressed both in absolute terms and as a percent
of the maximal reactive hyperemia ratio obtained in the
absence of a coronary stenosis. The percent of maximal
reactive hyperemia was determined by:
RH - 1
RHmax _ 1 x 100%.
where RH = measured reactive hyperemia associated with
any lesion, and RHmax = the maximal reactive hyperemia
associated with no coronary stenosis. In this way, a stenosis
producing no increase in postocclusion coronary blood flow
compared with basal coronary blood flow results in a re-
active hyperemia ratio of I (that is, a "critical" lesion) and
a percent maximal reactive hyperemia result of 0%. Stenoses
were characterized only by the extent to which they impaired
reactive hyperemia. Coronary blood flow during dopamine
infusion was expressed as a percent of coronary blood flow
at rest.
Statistical analysis. All data were analyzed using a one-
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way analysis of variance with a Scheffe multiple comparison
adjustment at a significance level of 0 .05 . When overalI
significance was detected , a Scheffe multiple compari son
analysis was used to determine which groups differed sig-
nificantly (6) . Data are reported as mean ± standard error
of the mean unless otherwise noted .
Results
Relation between coronary stenoses assessed by coro-
nary blood flow reserve and regional myocardial func-
tion during dopamine infusion. Table I shows the hemo-
dynamic variables at rest and during dopamine infusion in
subgroups defined by the percent of maximal coronary flow
reserve (0 to 5, 6 to 20, 21 to 40, 61 to 99 and 100%).
Heart rate increased approxim ately 120% during dopamine
infusion. Systolic blood pressure increased to approximately
160% of the control level. Moreover , coronary blood flow
increased to approximately 175% of the control level in
each subgroup despite the marked impairment of reactive
hyperemia detected at rest.
Table 2 shows the subendocardial segment shortening at
rest and during dopamine infusion. Mean segmental short-
ening in each subgroup was greater than or equal to 100%
of control values. Figure I shows that no consistent regional
dysfunction could be induced by dopamine infusion in the
presence of coronary stenoses associated with up to a total
loss of reactive hyperemia.
Relation between coronary blood flow and function
during dopamine infusion. Blood flow during dopamine
infusion was expressed as a percent of coronary blood flow
at rest before infusion . Observations are presented in relation
to six subgroups defined on the basis of this percent blood
flow at rest (0 to 50,51 to 100, 101 to 150, 151 to 200 and
>250%). Table 3 lists the hemodynamic data for these
subgroups and includes observations from the experiments
with graded subcritical coronary stenoses (eight dogs , 41
points described earlier) and from those in which graded
reduction in coronary blood flow was induced during steady
Table l. Hemodynamic Data at Rest and During Dopamine Infusion With Graded Coronary Stenoses
% Control Reactive Hyperemia
o to 5 6to 20 2 1 to 40 41 to 60 60 to 99 100 P Value
Heart rate (beats/min)
Rest 148 ± 9 153 ± 7 151 ± 10 153 ± 6 147 ± 10 149 ± 10 NS
Dopamine 175 ± 9 181 ± 5 183 ± 10 177 ± 5 180 ± 3 174 ± 8 NS
% Rest 119 ± 6 120 ± 5 124 ± 9 118 ± 8 125 ± 7 121 ± 8 NS
Systolic left ventricular pressure (mm Hg)
Rest 134 ± 5 138 ± 4 130 ± 4 132 ± 6 126 ± 8 138 ± 6 NS
Dopamine 231 ± 23 205 ± 17 206 ± 23 236 ± 17 211 ± 28 213 ± 13 NS
% Rest 172 ± 15 148 ± 9 158 ± 15 180 ± 15 168 ± 19 154 ± 8 NS
Rate-pressure product ( x to - 2)
Rest 201 ± 17 2 11 ± 13 195 ± 14 203 ± 16 187 ± 23 208 ± 21 NS
Dopamine 400 ± 40 372 ± 35 370 ± 38 419 ± 34 385 ± 58 367 ± 18 NS
% Rest 204 ± 20 176 ± 10 196 ± 25 214 ± 27 2 10 ± 27 185 ± 15 NS
Left ventricular end-diastolic pressure (mm Hg)
Resl 16 ± 2 14 ± 2 15 ± 2 13 ± I II ± I II ± 2 NS
Dopamine 14 ± 4 13 ± 4 12 ± 2 12 ± 3 13 ± 2 16 ± 3 NS
% Rest 94 ± 32 104 ± 20 79 ± 16 99 ±27 125 ± 27 156 ± 32 NS
Peak positive dP/dt (rnrn Hgls)
Rest 1,961 ± 121 2, 179 ± 108 2,069 ± 59 1,946 ± 162 1,965 ± 172 2, 197 ± 88 NS
Dopamine 4 ,668 ± 389 4,393 ±. 353 4,540 ± 332 4,767 ± 385 4,730 ± 522 4,3 19 ± 276 NS
% Rest 240 ± 18 201 ± 10 219 ± 13 248 ± 19 244 :!: 23 197 ± 13 NS
Peak negative dP/dt (mrn Hg/s)
Rest 1,636 ± 88 1,771 ± 84 1,756 ± 62 1,700 ± 124 1,710 ± 112 1,825 ± 104 NS
Dopamine 3,4 7 1 ± 359 3,136 ± 384 3,066 ± 350 3,533 ± 307 3,485 :!: 572 3, 166 ± 254 NS
% Rest 2 15 ± 23 175 ± 16 174 ± 19 209 ± 14 203 ± 30 173 ± II NS
Coronary blood flow (cc/ mi n)
Rest 38 ± 6 37 ± 5 35 ± 4 44 ± 5 39 :!: 5 44 ± 5 NS
Dopamine 69 ± 14 60 ± 12 6 1 ± 10 85 ± II 68 :!: 16 69 ± 7 NS
% Rest 171 ± 26 159 ± 25 158 ± 30 195 ± 24 170 ± 32 161 ± 13 NS
No. of observations 7 7 8 6 5 8
Data are reported as mean values ± standard error of the mean. dP/dt = rate of change of left ventricular pressure with time; NS = not signi ficant;
% Rest = variable measured during dopamine infusion expressed as a percent of the rest value .
JACC Vol. 5. No.3
March 1985:664-71
HODGSON AND MANCINI
ISCHEMIC DYSFUNCTION DURING DOPAMINE INFUSION
667
Table 2. Subendocardial Segment Shortening at Rest and During Dopamine Infusion With Graded Coronary Stenoses
% Control Reactive Hyperemia
o to 5 6 to 20 21 to 40 41 to 60 61 to 99 100 P Value
Ischemic (LAD)
% Shortening-R 19 ± 2 19 ± 2 23 ± I 19 ± 2 17 ± 2 22 ± II NS
% Shortening-D 20 ± 5 20 ± 4 26 ± 4 20 ± 3 18 ± 4 23 ± 2 NS
% Rest 101 ± 14 102 ± 12 113 ± 12 103 ± 8 103 ± 16 106 ± 5 NS
Nonischemic (LCx)
% Shortening-R 20 ± 3 20 ± 3 22 ± 2 22 ± 4 27 ± 2 19 ± 3 NS
% Shortening-D 22 ± 4 22 ± 3 23 ± 4 24 ± 7 26 ± 4 22 ± 1 NS
% Rest 115 ± 19 120 ± 15 117 ± 19 116 ± 23 96 ± 15 111 ± 13 NS
No. of observations 7 7 8 6 5 8
Data are reported as mean values ± standard error of the mean. D = dopamine infusion; LAD = left anterior descending coronary artery region;
LCx = left circumflex coronary artery region; R = at rest; other abbreviations as in Table I.
state dopamine infusion (seven dogs, 31 points). No sig-
nificant difference in heart rate response to dopamine in-
fusion was noted among subgroups. There was, however,
a significantly higher left ventricular systolic pressure in the
groups in which blood flow increased above control level
(p < 0.(05). In addition, left ventricular end-diastolic pres-
sure was higher in the subgroups with the greatest impair-
ment of blood flow (p < 0.0001). Both peak positive and
peak negative dP/dt were more greatly impaired in the groups
with the most profound limitations of blood flow during
infusion (p < 0.02).
Table 4 shows the segment shortening data during do-
Figure 1. The relation between graded impairments in coronary
blood flow reserve at rest (reactive hyperemia) and regional func-
tion (segment shortening) (expressed as a percent of control) during
dopamine infusion.
•
pamine infusion. The group data are displayed graphically
in Figure 2. Figure 3 shows the individual observations
during the reactive hyperemia investigation (n = 41) and
those obtained during the progressive blood flow impairment
investigation (n = 31). The two groups overlap in the 100%
coronary blood flow region at rest. The 31 points obtained
during dopamine infusion and progressive blood flow im-
pairment were best described by a polynomial equation: y
= 0.78x - 0.OO14x2 - 2.5 (r = 0.80, SEE = 29.5, P
< 0.(001), where y = percent of control segment short-
ening and x = percent of control coronary blood flow. The
points obtained during the protocol in which stenoses were
graded by the reactive hyperemic response at rest (n = 41)
were best fit by the equation: y = 0.36x - 0.OO05x2 +
58.8 (r = 0.40, SEE = 26.3, P < 0.04). All 72 points
together were best described by the polynomial equation: y
= 0.92x - 0.0018x2 + 0.54 (r = 0.74, SEE = 29.0, P
< 0.(001), whereas simple linear regression yielded a sig-
nificantly poorer fit (r = 0.64) .
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Discussion
Sympathomimetic agents have been used to assess car-
diac performance in patients with suspected coronary artery
disease since Levine et al. (7) first described the use of
subcutaneous epinephrine in 1930. Early reports (7,8) showed
conflicting results and were limited by the lack of a proper
standard by which to judge the sensitivity and specificity of
the procedure. More recently, however, investigators (9-12)
using several different sympathomimetic agents have de-
scribed excellent sensitivity and specificity for the detection
of angiographically defined coronary stenoses.
Clinical studies. Schechter et al. (9) defined a signifi-
cant coronary stenosis as one with 75% or greater reduction
in luminal diameter and found a diagnostic accuracy of 91%
using epinephrine infusion. Combs and Martin (0), how-
ever, defined significant stenoses as those with 50% or greater
reduction in luminal diameter and found a considerably lower
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Table 3. Hemodynamic Data at Rest and During Dopamine Infusion With Graded Impairment of Coronary Blood Flow
% Control Coronary Blood Row
oto 50 51 to 100 101 to 150 151 to 200 201 to 250 > 250 P Value
Heart rate (beats/min)
Rest 151 ± 10 148 ± 9 144 ± 5 148 ± 5 151 ± 9 151 ± 12 NS
Dopamine 158 ± 17 174 ± 14 188 ± 7 174 ± 5 191 ± 9 171 ± II NS
% Rest 108 ± 12 120 ± 12 134 ± 7 120 ± 4 133 ± II 118 ± II NS
Systolic left ventricular pressure (mm Hg)
Rest 135 ± 4 131 ± 5 129 ± 3 136 ± 3 130 ± 5 132 ± 4 NS
Dopamine 218 ± 8 204 ± 17 198 ± 9 229 ± 10 242 ± 14 262 ± 6 <0.005
% Rest 162 ± 8 158 ± 17 154 ± 6 170 ± 8 186 ± 8 200 ± 7 <0.006
Rate-pressure product (X 10- 2)
Rest 206 ± 19 197 ± 18 187 ± 10 203 ± IO 199 ± 17 203 ± 21 NS
Dopamine 338 ± 31 344 ± 25 370 ± 19 394 ± 16 457 ± 24 447 ± 28 <0.005
% Rest 171 ± 17 189 ± 28 209 ± 17 202 ± 13 246 ± 13 236 ± 33 NS
Left ventricular end-diastolic pressure (mm Hg)
Rest 9 ± 2 II ± 2 14 ± I I I ± I II ± 2 10 ± I NS
Dopamine 30 ± 6 13 ± 2 12 ± 2 I3 ± 2 13 ± 3 7 ± 2 <0.001
% Rest 397 ± 83 174 ± 44 92 ± 15 123 ± 21 108 ± 24 63 ± 20 <0.0001
Peak positive dP/dt (mm Hg/s)
Rest 2,168 ± 54 2,097 ± 142 1,870 ± 92 2,149 ± 48 1,835 ± 141 1,030 ± 119 NS
Dopamine 4,564 ± 153 4,275 ± 406 3.941 ± 202 4,787 ± 193 4,633 ± 391 5,455 ± 216 < 0.006
% Rest 211 ± 9 199 ± 17 213 ± 8 224 ± 10 254 ± 13 273 ± II < 0.0005
Peak negative dP/dt (mm Hg/s)
Rest 1,757 ± 94 1,697 ± 123 1,559 ± 80 1,806 ± 55 1,580 ± 118 1,674 ± 119 NS
Dopamine 3,221 ± 110 2,884 ± 297 2,736 ± 159 3,569 ± 138 3,402 ± 354 3,806 ± 235 < 0.006
% Rest 185 ± 8 173 ± 18 179 ± 10 200 ± 9 215 ± 15 230 ± 8 < 0.02
Coronary blood flow (cc/min)
Rest 38 ± 3 35 ± 5 39 ± 3 45 ± 3 38 ± 2 35 ± 2 NS
Dopamine 5 ± 3 26 ± 4 49 ± 4 75 ± 5 86 ± 5 102 ± 7 < 0.0001
% Rest 14 ± 7 71 ± 5 119 ± 8 170 ± 3 226 :!: 4 287 ± II < 0.0001
No. of observations 7 8 19 17 12 9
Data are reported as mean values ± standard error of the mean. Abbreviations as in Table I.
accuracy of 71% using isoproterenol infusion. There was a
high incidence of false negative results, particularly in pa-
tients with single vessel disease. Mason et al. (11) used
50% luminal narrowing as a definition of significant coro-
nary disease, and they also encountered false negative and
false positive results in patients with relatively mild coronary
stenoses. Likewise, Manca et al. (12) , using a variety of
sympathomimetic agents , found poor sensitivity (15 to 54%)
for the detectio n of single vessel lesions . These studies
suggest either that the use of sympathomimetic agents may
be insensitive in situations of angiographically mild or iso-
lated coronary lesions or that the angiographically visualized
lesions were, in fact, not hemodynamically significant.
Coronary blood flow reserve. Visual interpretation of
severity of coronary artery stenosis is inaccurate and not
reproducible (13-15). Gould et aI. (16) described the con-
Table 4, Subendocardial Segment Shortening at Rest and During Dopamine Infusion With Graded Impairment of
Coronary Blood Flow
% Control Coronary Blood Row
oto 50 51 to 100 101 to 150 lS I to 200 201 to 250 > 250 P Value
Ischemic (LAD)
% Shortening-R 18 ± 3 19 ± 2 19 ± I 18 ± 1 19 ± 2 20 ± I NS
% Shortening-D 3 ± 3 9 ± 3 19 ± 2 19 ± 2 22 ± 3 22 ± 1 < 0.0001
% Rest 16 ± 12 41 ± 16 97 ± 7 100 ± 7 \11 ± 8 11\ ± 5 < 0.0001
Nonischemic (LCx)
% Shortening-R 22 ± 3 23 ± 3 19 ± 1 18 ± 2 21 ± 3 24 ± 2 NS
% Shortening-D 23 ± 8 18 ± 5 17 ± 2 21 ± 2 22 ± 4 29 ± 4 NS
% Rest 88 ± 27 67 ± 20 90 ± 12 120 ± 13 \03 ± \7 109 ± 12 NS
Data are reported as mean values ± standard error of the mean. Abbreviations as in Table 2.
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Increases in left ventricular pressure, wall stress and
inotropic state will augment myocardial oxygen consump-
tion and cause coronary dilation and increased coronary
blood flow. In this investigation, increases in blood flow
and maintenance of regional function were most related to
the degree of pressure increase induced by dopamine treat-
ment (Table 3). These findings are consistent with those of
Vatner et al. (21), who also showed that preservation of
regional function was dependent on maintenance of coro-
nary perfusion pressure. Other investigators (22-24) found
that the heart rate response to dopamine or dobutamine
infusion was important in determining the development of
regional dysfunction due to impairment of diastolic coronary
flow. We did not find any differences in heart rate increases
between subgroups during dopamine infusion and, thus, no
differential effect of heart rate could be shown in this study
(Table 3). Therefore, in this investigation, the major de-
terminant of stress-induced regional dysfunction was coro-
nary blood flow which was, in tum, primarily dependent
on the pressor response associated with dopamine infusion.
Figure 3. The relation between coronary blood flow (expressed
as percent of rest levels) and regional function (segment shortening)
(expressed as a percent of control) during dopamine infusion. The
circles represent points determined during progressive impairment
in coronary blood flow (n = 31). The squares represent points
determined during progressive impairment of coronary blood flow
reserve (n = 41). All points (n = 72) were best described by the
polynomial equation: y = 0.92x - O.OO18x2 + 0.54 (r = 0.74,
SEE = 29.0, P < 0.0001), where y = percent of control segment
shortening and x = percent of control coronary blood flow (solid
line).
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Figure 2. The relation between coronary blood flow (expressed
as a percent of rest levels) and regional function (segment short-
ening) (expressed as a percent of control) during dopamine infu-
sion. Regional function was not impaired until coronary blood
flow decreased to less than rest levels below which function de-
teriorated rapidly.
cept of coronary blood flow reserve as an alternative method
of assessing the true hemodynamic significance of coronary
stenoses. Studies (17,18) comparing the hemodynamic sig-
nificance of coronary lesions with the angiographically de-
fined narrowing have shown poor correlation. Finally, func-
tional stress test abnormalities have been demonstrated in
patients with either angiographically normal coronary ar-
teries or mild coronary stenoses when physiologic assess-
ments of lesion severity based on coronary flow dynamics
were abnormal (19,20). This study used the measurement
of coronary flow reserve to characterize coronary stenoses
and, thereby, avoided the limitations of angiography. We
specifically produced subcritical lesions and provided evi-
dence that these mild to moderate coronary stenoses (as
defined by coronary flow reserve at rest) do not necessarily
result in regional dysfunction during sympathomimetic stress.
This could explain the clinical findings of "false negative"
results in the studies discussed earlier.
Coronary flow reserve at rest appears to be a more sen-
sitive indicator of coronary stenoses than is the detection
of dopamine-induced regional abnormalities. The lack of
correlation between coronary blood flow reserve at rest and
stress-induced regional dysfunction was, in large part, due
to the changes in coronary blood flow that occurred during
dopamine infusion (Table 3; Fig. 2 and 3). When coronary
blood flow either increased or remained at near rest levels,
function was maintained. However, when coronary blood
flow was less than 100% of rest levels, function deteriorated
rapidly.
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Other investigators (2,4,24-26) found a similar depen-
dence of stress-induced regional dysfunction on regional
blood flow. In studies in dogs at rest (27), during exercise
(26) and during isoproterenol infusion (2), Gallagher and
coworkers found that function was dependent on mainte-
nance of regional blood flow and, more importantly, that
the relation between regional function and blood flow was
the same at rest as it was during both exercise and isopro-
terenol infusion. In those studies, function began to dete-
riorate during stress when blood flow decreased to less than
150 to 200% of the rest level. We found function during
dopamine infusion to be maintained until blood flow is re-
duced to near rest levels, suggesting that dopamine infusion
is a less sensitive means of eliciting dysfunction than is
either isoproterenol infusion or exercise. Data in the com-
parative clinical study by Manca et al. (12) are compatible
with this finding. Specificity for the detection of coronary
stenoses (>50%) was only 41% using dopamine infusion
compared with 70% for isoproterenol infusion and 66% for
treadmill exercise.
Potential limitations of the study. These observations
were obtained in an anesthetized, acute, open chest dog
model. Anesthesia has marked influences on the coronary
and systemic hemodynamic responses to dopamine infusion
(28",29). These studies will, therefore, need corroboration
in a chronic, awake animal model.
As in other studies (2,3,5,16,26,27), an external occluder
was used to create coronary stenoses. Although lesions cre-
ated using this type of occluder are stable under rest con-
ditions, changes may occur during stress as perfusion pres-
sure and transstenotic gradients are altered (30-32). Even
severe, calcific, human coronary lesions have been dem-
onstrated to have considerable vasomotor tone and to undergo
geometric alteration with changes in perfusion pressure
(33-35). Therefore, the possibility of changes in severity
of experimental stenosis is a limitation of the model, but it
is also a reflection of changes that are possible in human
coronary stenoses. The most appropriate model of human
coronary stenoses is likely to be intermediate between totally
rigid and partially pliable. The rigid and noncompressible
occluders used in this study were not likely to have expanded
in the presence of the increased perfusion pressure induced
by dopamine. Nevertheless, confirmation of the results with
rigid intraluminal occluders would be desirable. Even so,
it is clear from Figures 2 and 3 that severe impairment of
relative coronary flow is required before dopamine can in-
duce regional dysfunction.
Conclusions. I) Coronary blood flow reserve at rest is
a valuable measure of corortary lesion severity, but sub-
critical impairments of this index do not predict regional
dysfunction during dopamine infusion, largely because the
determinants of coronary blood flow are markedly altered
during the infusion. 2) Augmented coronary perfusion pres-
sure due to the pressor effect of dopamine is a major de-
terminant of coronary blood flow during dopamine infusion.
3) Preservation of regional myocardial function during do-
pamine stress is dependent on maintenance of coronary blood
flow at or above rest levels.
This work has two major clinical implications. I) Tech-
niques to measure coronary flow reserve in human subjects
are becoming available (36-41). When impaired coronary
blood flow reserve is detected at rest, care should be taken
in predicting potential regional dysfunction during stresses
that alter the determinants of coronary blood flow as com-
pared with rest conditions. 2) Dopamine infusion is an in-
sensitive method of eliciting regional myocardial dysfunc-
tion in the presence of subcritical coronary stenoses.
We thank Diane Bauer for her expert preparation of this manuscript.
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